Altering the course of schizophrenia: progress and perspectives

Millan, M.J., Andrieux, A., Bartzokis, G., Cadenhead, K.S., Dazzan, P., Fusar‐Poli, P., Gallinat, J., Giedd, J.N., Grayson, D.R., Heinrichs, M., Kahn, R.S., Krebs, M., Leboyer, M., Lewis, D.A., Marín, �., Marin, P., Meyer‐Lindenberg, A., McGorry, P.D., McGuire, P., &amp; Owen, M.J. (2016). Altering the course of schizophrenia: progress and perspectives. <em>Nature Reviews Drug Discovery</em>. https://doi.org/10.1038/nrd.2016.28

Millan MJ, Andrieux A, Bartzokis G, Cadenhead KS, Dazzan P, Fusar‐Poli P, et al. Altering the course of schizophrenia: progress and perspectives. Nature Reviews Drug Discovery. 2016. doi:10.1038/nrd.2016.28.

@unpublished{mark2016Alteri, title = {Altering the course of schizophrenia: progress and perspectives}, author = {Mark J. Millan and Annie Andrieux and George Bartzokis and Kristin S. Cadenhead and Paola Dazzan and Paolo Fusar‐Poli and Jürgen Gallinat and Jay N. Giedd and Dennis R. Grayson and Markus Heinrichs and René S. Kahn and Marie‐Odile Krebs and Marion Leboyer and David A. Lewis and Òscar Marín and Philippe Marin and Andreas Meyer‐Lindenberg and Patrick D. McGorry and Philip McGuire and Michael J. Owen and Paul H. Patterson and Akira Sawa and Michael Spedding and Peter J. Uhlhaas and Flora M. Vaccarino}, journal = {Nature Reviews Drug Discovery}, year = {2016}, doi = {10.1038/nrd.2016.28}, }